| HGNC Family | Solute carriers (SLC) |
| Name | solute carrier family 47 (multidrug and toxin extrusion), member 2 |
| Description | This gene encodes a protein belonging to a family of transporters involved in excretion of toxic electrolytes, both endogenous and exogenous, through urine and bile. This transporter family shares homology with the bacterial MATE (multidrug and toxin extrusion) protein family responsible for drug resistance. This gene is one of two members of the MATE transporter family located near each other on chromosome 17. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC47A2 encodes the multidrug and toxin extrusion protein 2‐K (MATE2‐K), a proton/organic cation antiporter predominantly expressed at the apical (brush‐border) membranes of renal proximal tubular cells. It facilitates the secretion of a wide range of endogenous metabolites and exogenous compounds—including drugs such as metformin, tetraethylammonium, and certain anticancer agents—thereby contributing to renal detoxification and drug clearance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nWithin the kidney, the activity of SLC47A2/MATE2‐K is tightly regulated by both extracellular and intracellular signals to adjust organic cation secretion in response to physiological demands. Rapid regulatory mechanisms—including modulation by intracellular signaling pathways and environmental factors such as fluid shear stress via redox‐sensitive Nrf2 signaling—have been shown to alter transporter activity. Moreover, coordinated expression and colocalization with other renal transporters (e.g. OCT2, OAT1/3) further enable an efficient and adaptable vectorial drug secretion system."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "8"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGenetic variability in SLC47A2 can substantially influence MATE2‐K function. Several coding single nucleotide polymorphisms have been identified that either markedly reduce or—in rare cases—increase transporter activity, thereby affecting substrate handling of compounds such as metformin. In vitro studies using fluorescent probe substrates (e.g. DAPI) have demonstrated substrate‐dependent inhibition profiles and revealed clinically relevant interactions with inhibitors such as pazopanib. Although heterozygous variants sometimes do not show overt effects on drug disposition, these findings underscore the pharmacogenomic importance of SLC47A2 in drug–drug interactions and interindividual variability in therapeutic responses."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "14"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nEmerging evidence also points to roles for SLC47A2/MATE2‐K outside of classic renal excretion. Notably, a brain‐specific gene coexpression network implicated MATE2 as a central ciliary gene, thereby hinting at potential functions in ciliary signaling and neurobiology. In addition, epigenetic repression of SLC47A2 has been observed in renal cell carcinoma, with altered chromatin modifications and regulatory noncoding RNAs contributing to its downregulation—a change that may serve as a negative prognostic marker. These observations broaden the clinical significance of SLC47A2 to include implications for cancer biology and possibly other organ systems."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "18"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yuko Tanihara, Satohiro Masuda, Tomoko Sato, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Pharmacol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcp.2007.04.010"}], "href": "https://doi.org/10.1016/j.bcp.2007.04.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17509534"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17509534"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Moto Kajiwara, Tomohiro Terada, Ken Ogasawara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hum Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jhg.2008.1"}], "href": "https://doi.org/10.1038/jhg.2008.1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19158817"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19158817"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Kana Toyama, Atsushi Yonezawa, Masahiro Tsuda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e328335639f"}], "href": "https://doi.org/10.1097/FPC.0b013e328335639f"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20016398"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20016398"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Kin-ya Ohta, Katsuhisa Inoue, Tomoya Yasujima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional characteristics of two human MATE transporters: kinetics of cimetidine transport and profiles of inhibition by various compounds."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pharm Pharm Sci (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18433/j3r59x"}], "href": "https://doi.org/10.18433/j3r59x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20067714"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20067714"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "S L Stocker, K M Morrissey, S W Yee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Pharmacol Ther (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/clpt.2012.210"}], "href": "https://doi.org/10.1038/clpt.2012.210"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23267855"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23267855"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Hideyuki Motohashi, Yumi Nakao, Satohiro Masuda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Precise comparison of protein localization among OCT, OAT, and MATE in human kidney."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pharm Sci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jps.23567"}], "href": "https://doi.org/10.1002/jps.23567"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23630107"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23630107"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yasunori Fukuda, Misato Kaishima, Toshiyuki Ohnishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fluid shear stress stimulates MATE2-K expression via Nrf2 pathway activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.01.124"}], "href": "https://doi.org/10.1016/j.bbrc.2017.01.124"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28131833"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28131833"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Marta Kantauskaitė, Anna Hucke, Moritz Reike, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rapid Regulation of Human Multidrug and Extrusion Transporters hMATE1 and hMATE2K."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms21145157"}], "href": "https://doi.org/10.3390/ijms21145157"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32708212"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32708212"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Tomoya Yasujima, Kin-ya Ohta, Katsuhisa Inoue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of 4',6-diamidino-2-phenylindole as a fluorescent probe substrate for rapid assays of the functionality of human multidrug and toxin extrusion proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.109.030221"}], "href": "https://doi.org/10.1124/dmd.109.030221"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20047987"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20047987"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Kenta Nishimura, Ryosuke Ide, Takeshi Hirota, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and functional characterization of novel nonsynonymous variants in the human multidrug and toxin extrusion 2-K."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.114.056887"}], "href": "https://doi.org/10.1124/dmd.114.056887"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24985703"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24985703"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "C Sauzay, M White-Koning, I Hennebelle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacol Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.phrs.2016.05.012"}], "href": "https://doi.org/10.1016/j.phrs.2016.05.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27178732"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27178732"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Christian Lechner, Naoki Ishiguro, Ayano Fukuhara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impact of Experimental Conditions on the Evaluation of Interactions between Multidrug and Toxin Extrusion Proteins and Candidate Drugs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.115.068163"}], "href": "https://doi.org/10.1124/dmd.115.068163"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27271370"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27271370"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Gerard Marshall Raj, Jayanthi Mathaiyan, Mukta Wyawahare, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Pers Ther (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1515/dmpt-2018-0030"}], "href": "https://doi.org/10.1515/dmpt-2018-0030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30433870"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30433870"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Alma Faviola Favela-Mendoza, Ingrid Fricke-Galindo, Wendy Fernanda Cuevas-Sánchez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Population diversity of three variants of the SLC47A2 gene (MATE2-K transporter) in Mexican Mestizos and Native Americans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-021-06628-y"}], "href": "https://doi.org/10.1007/s11033-021-06628-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34383246"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34383246"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Alexander E Ivliev, Peter A C 't Hoen, Willeke M C van Roon-Mom, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exploring the transcriptome of ciliated cells using in silico dissection of human tissues."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0035618"}], "href": "https://doi.org/10.1371/journal.pone.0035618"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22558177"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22558177"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Qinqin Yu, Yanqing Liu, Xiaoli Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Histone H3 Lysine 4 Trimethylation, Lysine 27 Trimethylation, and Lysine 27 Acetylation Contribute to the Transcriptional Repression of Solute Carrier Family 47 Member 2 in Renal Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.116.073734"}], "href": "https://doi.org/10.1124/dmd.116.073734"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27821436"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27821436"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Sanjana Chowdhury, Eric Yung, Melania Pintilie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MATE2 Expression Is Associated with Cancer Cell Response to Metformin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0165214"}], "href": "https://doi.org/10.1371/journal.pone.0165214"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27959931"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27959931"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Zhangzhao Gao, Mengjiao Chen, Xueke Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel human lncRNA SANT1 "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "cis"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": "-regulates the expression of "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "SLC47A2"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " by altering SFPQ/E2F1/HDAC1 binding to the promoter region in renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "RNA Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15476286.2019.1602436"}], "href": "https://doi.org/10.1080/15476286.2019.1602436"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30951404"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30951404"}]}]}]}
|
| Synonyms | MATE2K, MATE2-K, MATE2, MATE2-B |
| Proteins | S47A2_HUMAN |
| NCBI Gene ID | 146802 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SLC47A2 has 2,410 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 85 datasets.
Click the + buttons to view associations for SLC47A2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC47A2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SLC47A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SLC47A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC47A2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC47A2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC47A2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC47A2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SLC47A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SLC47A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SLC47A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SLC47A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SLC47A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SLC47A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC47A2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SLC47A2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SLC47A2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SLC47A2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SLC47A2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SLC47A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SLC47A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SLC47A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SLC47A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for SLC47A2 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SLC47A2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC47A2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SLC47A2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SLC47A2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with SLC47A2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SLC47A2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SLC47A2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SLC47A2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC47A2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SLC47A2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SLC47A2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SLC47A2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SLC47A2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SLC47A2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SLC47A2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SLC47A2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SLC47A2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SLC47A2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SLC47A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SLC47A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC47A2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SLC47A2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding SLC47A2 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SLC47A2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SLC47A2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SLC47A2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC47A2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC47A2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SLC47A2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SLC47A2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC47A2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SLC47A2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by SLC47A2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SLC47A2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SLC47A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SLC47A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC47A2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SLC47A2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SLC47A2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SLC47A2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SLC47A2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SLC47A2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| NURSA Protein Complexes | protein complexs containing SLC47A2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SLC47A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SLC47A2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SLC47A2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving SLC47A2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving SLC47A2 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SLC47A2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SLC47A2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SLC47A2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of SLC47A2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands | ligand (protein) perturbations changing phosphorylation of SLC47A2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SLC47A2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SLC47A2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SLC47A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SLC47A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SLC47A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SLC47A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SLC47A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SLC47A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SLC47A2 protein from the WikiPathways Pathways 2024 dataset. | |